VanEck Biotech Ownership
| BBH Etf | USD 154.59 2.23 1.46% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
VanEck |
VanEck Etf Ownership Analysis
VanEck Biotech is is formed as Regulated Investment Company in the United States. ETF is managed and operated by Van Eck Associates Corporation. The fund has 26 constituents with avarage daily trading value of 8.6 K. The fund charges 0.35 percent management fee with a total expences of 0.35 percent of total asset. The fund holds 99.96% of assets under management (AUM) in equities. VanEck Biotech ETF last dividend was 0.472 per share. The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States. For more info on VanEck Biotech ETF please contact the company at NA.Sector Exposure (%)
Investors will always prefer to have their portfolios divercified against different sectors. The broad sector allocation increases the possibility of making a profit or at least avoiding a loss. However, this may also reduce the expected return on VanEck Etf. Generally, it depends on diversification level and type but usually, the broader the sector allocation, the less risk can be expected from holding VanEck Biotech , and the less return is expected.
Investment Allocations (%)
Top Etf Constituents
| BGNE | BeiGene | Stock | Cancer Fighters |
| ILMN | Illumina | Stock | Measuring and Control Equipment |
| VRTX | Vertex Pharmaceuticals | Stock | Pharmaceutical Products |
| SGEN | Seagen Inc | Stock | Seagen |
| REGN | Regeneron Pharmaceuticals | Stock | Biotech |
| NVAX | Novavax | Stock | Biotechnology |
| MRNA | Moderna | Stock | Biotechnology |
| IQV | IQVIA Holdings | Stock | Life Sciences Tools & Services |
| INCY | Incyte | Stock | Biotechnology |
| GILD | Gilead Sciences | Stock | Corona Opportunity |
| GH | Guardant Health | Stock | Healthcare |
| EXAS | EXACT Sciences | Stock | Biotechnology |
| CRL | Charles River Laboratories | Stock | Life Sciences Tools & Services |
| BMRN | Biomarin Pharmaceutical | Stock | Biotechnology |
| BIIB | Biogen Inc | Stock | Hedge Favorites |
| AMGN | Amgen Inc | Stock | Health Management |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VanEck Biotech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VanEck Biotech's short interest history, or implied volatility extrapolated from VanEck Biotech options trading.
Pair Trading with VanEck Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VanEck Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will appreciate offsetting losses from the drop in the long position's value.Moving together with VanEck Etf
| 0.89 | IBB | iShares Biotechnology ETF | PairCorr |
The ability to find closely correlated positions to VanEck Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace VanEck Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back VanEck Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling VanEck Biotech ETF to buy it.
The correlation of VanEck Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as VanEck Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if VanEck Biotech ETF moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for VanEck Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the VanEck Biotech ETF information on this page should be used as a complementary analysis to other VanEck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.